Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.44 CAD | 0.00% | +6.02% | -37.55% |
05-27 | Cytophage Technologies Ltd. Strengthens Board of Directors | CI |
04-30 | Cuspis Capital III Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Business Summary
Managers
Managers | Title | Age | Since |
---|---|---|---|
Steven Theriault
CEO | Chief Executive Officer | - | 02-07 |
Julius Kalcevich
DFI | Director of Finance/CFO | 49 | 02-07 |
Heather Medwick
COO | Chief Operating Officer | - | 02-07 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Harold Wolkin
CHM | Chairman | 72 | - |
Andrew Hurley
BRD | Director/Board Member | - | - |
Steven Theriault
CEO | Chief Executive Officer | - | 02-07 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 53,753,355 | 45,636,609 ( 84.90 %) | 0 | 84.90 % |
Company contact information
Sector
1st Jan change | Capi. | |
---|---|---|
-37.55% | 17.2M | |
+50.70% | 791B | |
+41.96% | 630B | |
-7.15% | 350B | |
+18.77% | 328B | |
+8.79% | 298B | |
+18.02% | 246B | |
+1.27% | 225B | |
+11.95% | 218B | |
+3.68% | 160B |
- Stock Market
- Equities
- CYTO Stock
- Company Cytophage Technologies Ltd.